| Metric | შპს ბიოტეკსი | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾6.7m₾5.9m | ₾2.36bn₾2.11bn |
| Revenue growth | 13.9% | 11.8% |
| Profitability | ||
| EBITDA | ₾1.3m₾1.0m | — |
| EBITDA margin | 19.6%17.5% | — |
| Net profit | ₾1.3m₾1.1m | ₾1.24bn₾1.12bn |
| Net margin | 19.0%18.2% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾9.1m₾7.1m | ₾37.66bn₾31.77bn |
| Total equity | ₾8.0m₾6.9m | ₾5.45bn₾4.75bn |
| ROE | 15.9%15.6% | 22.8%23.6% |